Tinea corporis is contagious infection which can spread from one person to other hence it is important not to share towel, flannels, bathmats with another person. Tinea corporis is a fungal infection that is caused by tinea rubrum, trichophyton mentagrophytes and epidermophyton floccosum fungi.
This fungal infection mainly occurs in humid climatic condition. It is also known as ringworm infection. Tinea corporis infection occurs mostly on arms, legs or can also occur on different parts of body. The global Tinea Corporis Market Size is expected to see the growth in upcoming year due to entry of new drug product in market for treatment. Many key players in market are engaged in development of new drug product for tinea corporis treatment.
Global Tinea Corporis Market Size is expected to rise steadily at a CAGR of 7.2% during forecast period of 2018-2023.
Avail Free Sample at https://www.marketresearchfuture.com/sample_request/6838
Market Segmentation:
Global Tinea Corporis Market Size is segmented into drug type, diagnosis, treatment and end-users. Tinea Corporis Market Size on basis of drug types is segmented into antifungals, steroids and anti-infective combinations.
Global Tinea Corporis Market Size by Drug Type
Antifungals
Steroids
Anti-Infective Combinations
Global Tinea Corporis Market Size, by Diagnosis
Physical Exam
Imaging Tests Wood lamp (black light) examination Microscopy using potassium hydroxide (KOH) Fungal culture Skin biopsy Others
Global Tinea Corporis Market Size, by Treatment
Antifungal shampoos
Antifungal creams
Drugs
Others
Global Tinea Corporis Market Size, by End-Users
Hospital Pharmacies
Drug Stores
Online Pharmacies
Dermatology hospitals
Others
Top Industry Key players:
Some of the key players in the global Tinea Corporis Market Size are –
Teva Pharmaceuticals Inc.
Glenmark Pharmaceuticals Inc
NorthStar Rx LLC
Aurobindo Pharma Limited
Camber Pharmaceuticals Inc.
AvKare Inc.
Novartis AG
Sebela Pharmaceuticals Inc.
Bayer AG
Blueberry Therapeutics Ltd
Perrigo Company
Taro Pharmaceuticals. Inc.
Breckenridge Pharmaceutical Inc.
Browse Complete Premium Research Report Enabled with TOC at https://www.marketresearchfuture.com/reports/tinea-corporis-market-6838
Regional Market Summary
Geographically, the America holds the highest market share for Tinea Corporis Market Size and the reason being many market players are engaged in development of new drug product innovation, and as this infection is more prone to humid climatic condition there is an increasing prevalence of fungal infection in this region. Whereas increasing awareness of fungal disease and rising healthcare expenditure by the government are some of the factors responsible for growth of market in this region
Europe is expected to be the second largest market in the globe owing to the increasing aging population, increasing prevalence of fungal infection, focus on aesthetic appearance, increasing research base. Whereas rise in susceptible immune compromised patient population is responsible for market growth in this region.
Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of fungal infection, changing lifestyle, increase in population, increasing healthcare expenditure by government are some of the factor responsible for market growth in this region.
About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Comments